Modulation of experimental autoimmune encephalomyelitis through colonisation of the gut with Escherichia coli
äºBeneficial MicrobesSearch for other papers by J.E. Libbey in
Current site
Google Scholar
Search for other papers by J.M.S. Sanchez in
Current site
Google Scholar
Search for other papers by B.A. Fleming in
Current site
Google Scholar
Search for other papers by D.J. Doty in
Current site
Google Scholar
Search for other papers by A.B. DePaula-Silva in
Current site
Google Scholar
Search for other papers by M.A. Mulvey in
Current site
Google Scholar
Search for other papers by R.S. Fujinami in
Current site
Google Scholar
Multiple sclerosis (MS) is a neuro-inflammatory autoimmune disease of the central nervous system (CNS) that affects young adults. It is characterised by the development of demyelinating lesions and inflammation within the CNS. Although the causes of MS are still elusive, recent work using patient samples and experimental animal models has demonstrated a strong relationship between the gut microbiota and its contribution to CNS inflammation and MS. While there is no cure for MS, alteration of the gut microbiota composition through the use of probiotics is a very promising treatment. However, while most recent works have focused on the use of probiotics to modify pre-existing disease, little is known about its role in protecting from the establishment of MS. In this study, we determined whether colonisation with the probiotic bacterium Escherichia coli strain Nissle 1917 (EcN) could be used as a prophylactic strategy to prevent or alter the development of experimental autoimmune encephalomyelitis (EAE), a preclinical model of MS. We found that double gavage (two doses) of EcN before induction of EAE delayed disease onset and decreased disease severity. We also found that EcN-treated mice had decreased amounts of perivascular cuffing, CD4+ T cell infiltration into the CNS, together with significantly decreased absolute numbers of Th1 cells, and reduced activation of microglia. Although further studies are necessary to comprehend the exact protective mechanisms induced, our study supports a promising use of EcN as a probiotic for the prevention of MS.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
-
Arellano, G., Ottum, P.A., Reyes, L.I., Burgos, P.I. and Naves, R., 2015. Stage-specific role of interferon-gamma in experimental autoimmune encephalomyelitis and multiple sclerosis. Frontiers in Immunology 6: 492.
'Stage-specific role of interferon-gamma in experimental autoimmune encephalomyelitis and multiple sclerosis ' () 6 Frontiers in Immunology : 492.
-
Cekanaviciute, E., Yoo, B.B., Runia, T.F., Debelius, J.W., Singh, S., Nelson, C.A., Kanner, R., Bencosme, Y., Lee, Y.K., Hauser, S.L., Crabtree-Hartman, E., Sand, I.K., Gacias, M., Zhu, Y., Casaccia, P., Cree, B.A.C., Knight, R., Mazmanian, S.K. and Baranzini, S.E., 2017. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proceedings of the National Academy of Sciences of the USA 114: 10713-10718.
'Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models ' () 114 Proceedings of the National Academy of Sciences of the USA : 10713 -10718.
-
Chen, J., Chia, N., Kalari, K.R., Yao, J.Z., Novotna, M., Paz Soldan, M.M., Luckey, D.H., Marietta, E.V., Jeraldo, P.R., Chen, X., Weinshenker, B.G., Rodriguez, M., Kantarci, O.H., Nelson, H., Murray, J.A. and Mangalam, A.K., 2016. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Scientific Reports 6: 28484.
'Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls ' () 6 Scientific Reports : 28484.
-
Colpitts, S.L. and Kasper, L.H., 2017. Influence of the gut microbiome on autoimmunity in the central nervous system. Journal of Immunology 198: 596-604.
'Influence of the gut microbiome on autoimmunity in the central nervous system ' () 198 Journal of Immunology : 596 -604.
-
Cosorich, I., Dalla-Costa, G., Sorini, C., Ferrarese, R., Messina, M.J., Dolpady, J., Radice, E., Mariani, A., Testoni, P.A., Canducci, F., Comi, G., Martinelli, V. and Falcone, M., 2017. High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis. Science Advances 3: e1700492.
'High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis ' () 3 Science Advances : e1700492.
-
Dargahi, N., Johnson, J., Donkor, O., Vasiljevic, T. and Apostolopoulos, V., 2019. Immunomodulatory effects of probiotics: can they be used to treat allergies and autoimmune diseases? Maturitas 119: 25-38.
'Immunomodulatory effects of probiotics: can they be used to treat allergies and autoimmune diseases? ' () 119 Maturitas : 25 -38.
-
Duong, T.T., St Louis, J., Gilbert, J.J., Finkelman, F.D. and Strejan, G.H., 1992. Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. Journal of Neuroimmunology 36: 105-115.
'Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse ' () 36 Journal of Neuroimmunology : 105 -115.
-
Freedman, S.N., Shahi, S.K. and Mangalam, A.K., 2018. The âgut feelingâ: breaking down the role of gut microbiome in multiple sclerosis. Neurotherapeutics 15: 109-125.
'The âgut feelingâ: breaking down the role of gut microbiome in multiple sclerosis ' () 15 Neurotherapeutics : 109 -125.
-
He, B., Hoang, T.K., Tian, X., Taylor, C.M., Blanchard, E., Luo, M., Bhattacharjee, M.B., Freeborn, J., Park, S., Couturier, J., Lindsey, J.W., Tran, D.Q., Rhoads, J.M. and Liu, Y., 2019. Lactobacillus reuteri reduces the severity of experimental autoimmune encephalomyelitis in mice by modulating gut microbiota. Frontiers in Immunology 10: 385.
'Lactobacillus reuteri reduces the severity of experimental autoimmune encephalomyelitis in mice by modulating gut microbiota ' () 10 Frontiers in Immunology : 385.
-
Heesen, C., Gold, S.M., Huitinga, I. and Reul, J.M., 2007. Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis â a review. Psychoneuroendocrinology 32: 604-618.
'Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis â a review ' () 32 Psychoneuroendocrinology : 604 -618.
-
Jangi, S., Gandhi, R., Cox, L.M., Li, N., Von Glehn, F., Yan, R., Patel, B., Mazzola, M.A., Liu, S., Glanz, B.L., Cook, S., Tankou, S., Stuart, F., Melo, K., Nejad, P., Smith, K., Topcuolu, B.D., Holden, J., Kivisakk, P., Chitnis, T., De Jager, P.L., Quintana, F.J., Gerber, G.K., Bry, L. and Weiner, H.L., 2016. Alterations of the human gut microbiome in multiple sclerosis. Nature Communications 7: 12015.
'Alterations of the human gut microbiome in multiple sclerosis ' () 7 Nature Communications : 12015.
-
Kipp, M., Nyamoya, S., Hochstrasser, T. and Amor, S., 2017. Multiple sclerosis animal models: a clinical and histopathological perspective. Brain Patholology 27: 123-137.
'Multiple sclerosis animal models: a clinical and histopathological perspective ' () 27 Brain Patholology : 123 -137.
-
Kouchaki, E., Tamtaji, O.R., Salami, M., Bahmani, F., Daneshvar Kakhaki, R., Akbari, E., Tajabadi-Ebrahimi, M., Jafari, P. and Asemi, Z., 2017. Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition 36: 1245-1249.
'Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial ' () 36 Clinical Nutrition : 1245 -1249.
-
Kwon, H.K., Kim, G.C., Kim, Y., Hwang, W., Jash, A., Sahoo, A., Kim, J.E., Nam, J.H. and Im, S.H., 2013. Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response. Clinical Immunology 146: 217-227.
'Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response ' () 146 Clinical Immunology : 217 -227.
-
Lane, M.C., Alteri, C.J., Smith, S.N. and Mobley, H.L., 2007. Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proceedings of the National Academy of Sciences of the USA 104: 16669-16674.
'Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract ' () 104 Proceedings of the National Academy of Sciences of the USA : 16669 -16674.
-
Lavasani, S., Dzhambazov, B., Nouri, M., Fak, F., Buske, S., Molin, G., Thorlacius, H., Alenfall, J., Jeppsson, B. and Westrom, B., 2010. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS ONE 5: e9009.
'A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells ' () 5 PLoS ONE : e9009.
-
Lee, Y.K., Menezes, J.S., Umesaki, Y. and Mazmanian, S.K., 2011. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the USA 108, Suppl. 1: 4615-4622.
'Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis ' () 1 : 4615 -4622.
-
Libbey, J.E. and Fujinami, R.S., 2011. Experimental autoimmune encephalomyelitis as a testing paradigm for adjuvants and vaccines. Vaccine 29: 3356-3362.
'Experimental autoimmune encephalomyelitis as a testing paradigm for adjuvants and vaccines ' () 29 Vaccine : 3356 -3362.
-
Libbey, J.E., Sanchez, J.M., Doty, D.J., Sim, J.T., Cusick, M.F., Cox, J.E., Fischer, K.F., Round, J.L. and Fujinami, R.S., 2018. Variations in diet cause alterations in microbiota and metabolites that follow changes in disease severity in a multiple sclerosis model. Beneficial Microbes 9: 495-513.
'Variations in diet cause alterations in microbiota and metabolites that follow changes in disease severity in a multiple sclerosis model ' () 9 Beneficial Microbes : 495 -513.
-
Libbey, J.E., Tsunoda, I. and Fujinami, R.S., 2010. Studies in the modulation of experimental autoimmune encephalomyelitis. Journal of Neuroimmune Pharmacology 5: 168-175.
'Studies in the modulation of experimental autoimmune encephalomyelitis ' () 5 Journal of Neuroimmune Pharmacology : 168 -175.
-
Loleit, V., Biberacher, V. and Hemmer, B., 2014. Current and future therapies targeting the immune system in multiple sclerosis. Current Pharmaceutical Biotechnology 15: 276-296.
'Current and future therapies targeting the immune system in multiple sclerosis ' () 15 Current Pharmaceutical Biotechnology : 276 -296.
-
Lublin, F.D., Knobler, R.L., Kalman, B., Goldhaber, M., Marini, J., Perrault, M., DâImperio, C., Joseph, J., Alkan, S.S. and Korngold, R., 1993. Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis. Autoimmunity 16: 267-274.
'Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis ' () 16 Autoimmunity : 267 -274.
-
Maltby, R., Leatham-Jensen, M.P., Gibson, T., Cohen, P.S. and Conway, T., 2013. Nutritional basis for colonization resistance by human commensal Escherichia coli strains HS and Nissle 1917 against E. coli O157:H7 in the mouse intestine. PLoS ONE 8: e53957.
'Nutritional basis for colonization resistance by human commensal Escherichia coli strains HS and Nissle 1917 against E. coli O157:H7 in the mouse intestine ' () 8 PLoS ONE : e53957.
-
Mangalam, A., Shahi, S.K., Luckey, D., Karau, M., Marietta, E., Luo, N., Choung, R.S., Ju, J., Sompallae, R., Gibson-Corley, K., Patel, R., Rodriguez, M., David, C., Taneja, V. and Murray, J., 2017. Human gut-derived commensal bacteria suppress CNS inflammatory and demyelinating disease. Cell Reports 20: 1269-1277.
'Human gut-derived commensal bacteria suppress CNS inflammatory and demyelinating disease ' () 20 Cell Reports : 1269 -1277.
-
McGeachy, M.J., Stephens, L.A. and Anderton, S.M., 2005. Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. Journal of Immunology 175: 3025-3032.
'Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system ' () 175 Journal of Immunology : 3025 -3032.
-
Miyake, S., Kim, S., Suda, W., Oshima, K., Nakamura, M., Matsuoka, T., Chihara, N., Tomita, A., Sato, W., Kim, S.W., Morita, H., Hattori, M. and Yamamura, T., 2015. Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters. PLoS ONE 10: e0137429.
'Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters ' () 10 PLoS ONE : e0137429.
-
Mowry, E.M. and Glenn, J.D., 2018. The dynamics of the gut microbiome in multiple sclerosis in relation to disease. Neurologic Clinics 36: 185-196.
'The dynamics of the gut microbiome in multiple sclerosis in relation to disease ' () 36 Neurologic Clinics : 185 -196.
-
National Multiple Sclerosis Society (NMSS), 2016. Medications. Available at: http://www.nationalmssociety.org/Treating-MS/Medications.
-
National Multiple Sclerosis Society (NMSS), 2018. Multiple sclerosis: just the facts. Available at: https://tinyurl.com/ybn2pvvl.
-
Ochoa-Reparaz, J., Mielcarz, D.W., Ditrio, L.E., Burroughs, A.R., Foureau, D.M., Haque-Begum, S. and Kasper, L.H., 2009. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. Journal of Immunology 183: 6041-6050.
'Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis ' () 183 Journal of Immunology : 6041 -6050.
-
Ãzdemir, Ã. and Göksu-Erol, A., 2012. Probiotics for autoimmune diseases: is there a benefit? In: Ãzdemir, Ã. (ed.) Contemporary pediatrics. InTech, London, UK, pp. 153-180.
'Probiotics for autoimmune diseases: is there a benefit? ', () 153 -180.
-
Pharma-Zentrale GmbH, 2019. Mutaflor® â with the unique probiotic active ingredient Escherichia coli strain Nissle 1917 for human gut health. Available at: https://www.mutaflor.com/index.html
-
Roy Sarkar, S. and Banerjee, S., 2019. Gut microbiota in neurodegenerative disorders. Journal of Neuroimmunology 328: 98-104.
'Gut microbiota in neurodegenerative disorders ' () 328 Journal of Neuroimmunology : 98 -104.
-
Salehipour, Z., Haghmorad, D., Sankian, M., Rastin, M., Nosratabadi, R., Soltan Dallal, M.M., Tabasi, N., Khazaee, M., Nasiraii, L.R. and Mahmoudi, M., 2017. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance. Biomedicine and Pharmacotherapy 95: 1535-1548.
'Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance ' () 95 Biomedicine and Pharmacotherapy : 1535 -1548.
-
Secher, T., Brehin, C. and Oswald, E., 2016. Early settlers: which E. coli strains do you not want at birth? American Journal of Physiology â Gastrointestinal and Liver Physiology 311: G123-G129.
'Early settlers: which E. coli strains do you not want at birth? ' () 311 American Journal of Physiology â Gastrointestinal and Liver Physiology : G123 -G129.
-
Secher, T., Kassem, S., Benamar, M., Bernard, I., Boury, M., Barreau, F., Oswald, E. and Saoudi, A., 2017. Oral administration of the probiotic strain Escherichia coli Nissle 1917 reduces susceptibility to neuroinflammation and repairs experimental autoimmune encephalomyelitis-induced intestinal barrier dysfunction. Frontiers in Immunology 8: 1096.
'Oral administration of the probiotic strain Escherichia coli Nissle 1917 reduces susceptibility to neuroinflammation and repairs experimental autoimmune encephalomyelitis-induced intestinal barrier dysfunction ' () 8 Frontiers in Immunology : 1096.
-
Shahi, S.K., Freedman, S.N. and Mangalam, A.K., 2017. Gut microbiome in multiple sclerosis: the players involved and the roles they play. Gut Microbes 8: 607-615.
'Gut microbiome in multiple sclerosis: the players involved and the roles they play ' () 8 Gut Microbes : 607 -615.
-
Shahi, S.K., Freedman, S.N., Murra, A.C., Zarei, K., Sompallae, R., Gibson-Corley, K.N., Karandikar, N.J., Murray, J.A. and Mangalam, A.K., 2019. Prevotella histicola, a human gut commensal, is as potent as COPAXONE(R) in an animal model of multiple sclerosis. Frontiers in Immunology 10: 462.
'Prevotella histicola, a human gut commensal, is as potent as COPAXONE(R) in an animal model of multiple sclerosis ' () 10 Frontiers in Immunology : 462.
-
Sonnenborn, U., 2016. Escherichia coli strain Nissle 1917-from bench to bedside and back: history of a special Escherichia coli strain with probiotic properties. FEMS Microbiology Letters 363: fnw212.
'Escherichia coli strain Nissle 1917-from bench to bedside and back: history of a special Escherichia coli strain with probiotic properties ' () 363 FEMS Microbiology Letters : fnw212.
-
Sosa, R.A., Murphey, C., Robinson, R.R. and Forsthuber, T.G., 2015. IFN-gamma ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation. Proceedings of the National Academy of Sciences of the USA 112: E5038-5047.
'IFN-gamma ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation ' () 112 Proceedings of the National Academy of Sciences of the USA : E5038 -5047.
-
Tankou, S.K., Regev, K., Healy, B.C., Tjon, E., Laghi, L., Cox, L.M., Kivisakk, P., Pierre, I.V., Hrishikesh, L., Gandhi, R., Cook, S., Glanz, B., Stankiewicz, J. and Weiner, H.L., 2018. A probiotic modulates the microbiome and immunity in multiple sclerosis. Annals of Neurology 83: 1147-1161.
'A probiotic modulates the microbiome and immunity in multiple sclerosis ' () 83 Annals of Neurology : 1147 -1161.
-
Van den Hoogen, W.J., Laman, J.D. and ât Hart, B.A., 2017. Modulation of multiple sclerosis and its animal model experimental autoimmune encephalomyelitis by food and gut microbiota. Frontiers in Immunology 8: 1081.
'Modulation of multiple sclerosis and its animal model experimental autoimmune encephalomyelitis by food and gut microbiota ' () 8 Frontiers in Immunology : 1081.
-
White, M.P.J., Webster, G., Leonard, F. and La Flamme, A.C., 2018. Innate IFN-gamma ameliorates experimental autoimmune encephalomyelitis and promotes myeloid expansion and PDL-1 expression. Scientific Reports 8: 259.
'Innate IFN-gamma ameliorates experimental autoimmune encephalomyelitis and promotes myeloid expansion and PDL-1 expression ' () 8 Scientific Reports : 259.
-
Yokote, H., Miyake, S., Croxford, J.L., Oki, S., Mizusawa, H. and Yamamura, T., 2008. NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora. American Journal of Pathology 173: 1714-1723.
'NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora ' () 173 American Journal of Pathology : 1714 -1723.
Supplementary Materials
| å ¨é¨æé´ | è¿å»ä¸å¹´ | è¿å»30天 | |
|---|---|---|---|
| æè¦æµè§æ¬¡æ° | 638 | 243 | 14 |
| å ¨ææµè§æ¬¡æ° | 28 | 8 | 0 |
| PDFä¸è½½æ¬¡æ° | 59 | 15 | 0 |
Modulation of experimental autoimmune encephalomyelitis through colonisation of the gut with Escherichia coli
äºBeneficial MicrobesSearch for other papers by J.E. Libbey in
Current site
Google Scholar
PubMed
Search for other papers by J.M.S. Sanchez in
Current site
Google Scholar
PubMed
Search for other papers by B.A. Fleming in
Current site
Google Scholar
PubMed
Search for other papers by D.J. Doty in
Current site
Google Scholar
PubMed
Search for other papers by A.B. DePaula-Silva in
Current site
Google Scholar
PubMed
Search for other papers by M.A. Mulvey in
Current site
Google Scholar
PubMed
Search for other papers by R.S. Fujinami in
Current site
Google Scholar
PubMed
Multiple sclerosis (MS) is a neuro-inflammatory autoimmune disease of the central nervous system (CNS) that affects young adults. It is characterised by the development of demyelinating lesions and inflammation within the CNS. Although the causes of MS are still elusive, recent work using patient samples and experimental animal models has demonstrated a strong relationship between the gut microbiota and its contribution to CNS inflammation and MS. While there is no cure for MS, alteration of the gut microbiota composition through the use of probiotics is a very promising treatment. However, while most recent works have focused on the use of probiotics to modify pre-existing disease, little is known about its role in protecting from the establishment of MS. In this study, we determined whether colonisation with the probiotic bacterium Escherichia coli strain Nissle 1917 (EcN) could be used as a prophylactic strategy to prevent or alter the development of experimental autoimmune encephalomyelitis (EAE), a preclinical model of MS. We found that double gavage (two doses) of EcN before induction of EAE delayed disease onset and decreased disease severity. We also found that EcN-treated mice had decreased amounts of perivascular cuffing, CD4+ T cell infiltration into the CNS, together with significantly decreased absolute numbers of Th1 cells, and reduced activation of microglia. Although further studies are necessary to comprehend the exact protective mechanisms induced, our study supports a promising use of EcN as a probiotic for the prevention of MS.
| å ¨é¨æé´ | è¿å»ä¸å¹´ | è¿å»30天 | |
|---|---|---|---|
| æè¦æµè§æ¬¡æ° | 638 | 243 | 14 |
| å ¨ææµè§æ¬¡æ° | 28 | 8 | 0 |
| PDFä¸è½½æ¬¡æ° | 59 | 15 | 0 |
